Polar Capital Holdings Plc 13D and 13G filings for Infinity Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:59 pm Sale |
2022-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Polar Capital Holdings Plc | 2,071,242 2.300% |
-2,928,758 (-58.58%) |
Filing |
| 2022-02-14 10:41 am Purchase |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Polar Capital Holdings Plc | 5,000,000 5.600% |
5,000,000 (New Position) |
Filing |